LUNG insider transaction filings
Pulmonx Corp — 42 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-09. Screen LUNG transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-09 | 4 | Sullivan Tiffany — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-06-09 | 4 | Melenikiotou Georgia — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-06-09 | 4 | Burns Thomas William — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-06-09 | 4 | Florin Daniel P — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-06-09 | 4 | Mead Dana G Jr. — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-06-09 | 4 | Ferrari Richard — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-06-03 | 4 | Radhakrishnan Srikanth — Chief Science &Techn. Officer | Sale (S): 2,691 @ $1.54 · Sale (S): 2,153 @ $1.54 · Sale (S): 3,684 @ $1.54 · Sale (S): 5,969 @ $1.54 | EDGAR |
| 2026-06-03 | 4 | French Glendon E. III — President and CEO, Director | Sale (S): 4,171 @ $1.54 · Sale (S): 38,467 @ $1.54 · Sale (S): 13,511 @ $1.57 | EDGAR |
| 2026-06-03 | 4 | Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER | Sale (S): 1,778 @ $1.54 · Sale (S): 1,557 @ $1.54 · Sale (S): 2,434 @ $1.54 · Sale (S): 2,254 @ $1.54 | EDGAR |
| 2026-06-03 | 4 | Lehman David Aaron — GENERAL COUNSEL | Sale (S): 3,876 @ $1.54 · Sale (S): 2,264 @ $1.54 · Sale (S): 3,539 @ $1.54 · Sale (S): 4,915 @ $1.54 | EDGAR |
| 2026-03-04 | 4 | Radhakrishnan Srikanth — Chief Science &Techn. Officer | Sale (S): 756 @ $1.43 · Sale (S): 3,068 @ $1.43 · Sale (S): 2,461 @ $1.43 · Sale (S): 4,198 @ $1.43 · Grant/award (A): 175,000 @ $0 | EDGAR |
| 2026-03-04 | 4 | French Glendon E. III — President and CEO, Director | Sale (S): 2,708 @ $1.43 · Sale (S): 6,737 @ $1.43 · Sale (S): 58,368 @ $1.43 | EDGAR |
| 2026-03-04 | 4 | Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER | Sale (S): 835 @ $1.43 · Sale (S): 2,125 @ $1.43 · Sale (S): 1,861 @ $1.43 · Sale (S): 2,911 @ $1.43 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-03-04 | 4 | Lehman David Aaron — GENERAL COUNSEL | Sale (S): 1,163 @ $1.43 · Sale (S): 4,433 @ $1.43 · Sale (S): 2,590 @ $1.43 · Sale (S): 4,051 @ $1.43 · Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-12-09 | 4 | Florin Daniel P — Director | Sale (S): 23,321 @ $1.99 | EDGAR |
| 2025-12-03 | 4 | French Glendon E. III — President and CEO, Director | Sale (S): 2,524 @ $1.57 · Sale (S): 6,281 @ $1.57 · Grant/award (A): 1,200,000 @ $0 · Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER | Sale (S): 683 @ $1.57 · Sale (S): 1,738 @ $1.57 · Sale (S): 1,522 @ $1.57 · Sale (S): 2,379 @ $1.57 | EDGAR |
| 2025-12-03 | 4 | Sung Derrick — COO and CFO | Grant/award (A): 1,200,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Lehman David Aaron — GENERAL COUNSEL | Sale (S): 976 @ $1.57 · Sale (S): 3,725 @ $1.57 · Sale (S): 2,176 @ $1.57 · Sale (S): 3,401 @ $1.57 | EDGAR |
| 2025-09-03 | 4 | Williamson Steven S. — PRESIDENT AND CEO, Director | Sale (S): 5,118 @ $1.60 · Sale (S): 4,530 @ $1.60 | EDGAR |
| 2025-09-03 | 4 | Joshi Mehul — Chief Financial Officer & PAO | Sale (S): 4,271 @ $1.60 · Sale (S): 3,665 @ $1.60 | EDGAR |
| 2025-09-03 | 4 | Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER | Sale (S): 707 @ $1.60 · Sale (S): 1,799 @ $1.60 · Sale (S): 1,575 @ $1.60 · Sale (S): 2,462 @ $1.60 | EDGAR |
| 2025-09-03 | 4 | Lehman David Aaron — GENERAL COUNSEL | Sale (S): 929 @ $1.60 · Sale (S): 3,541 @ $1.60 · Sale (S): 2,068 @ $1.60 · Sale (S): 3,231 @ $1.60 | EDGAR |
| 2025-06-13 | 4 | Ferrari Richard — Director | Sale (S): 8,000 @ $3.16 | EDGAR |
| 2025-06-05 | 4 | Florin Daniel P — Director | Purchase (P): 23,321 @ $3.06 | EDGAR |
| 2025-06-04 | 4 | Sullivan Tiffany — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-06-04 | 4 | Burns Thomas William — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-06-04 | 4 | Williamson Steven S. — PRESIDENT AND CEO, Director | Sale (S): 5,262 @ $3.13 · Sale (S): 4,661 @ $3.13 | EDGAR |
| 2025-06-04 | 4 | Joshi Mehul — Chief Financial Officer & PAO | Sale (S): 4,340 @ $3.13 · Sale (S): 3,721 @ $3.13 | EDGAR |
| 2025-06-04 | 4 | French Glendon E. III — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-06-04 | 4 | Melenikiotou Georgia — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-06-04 | 4 | Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER | Sale (S): 401 @ $3.14 · Sale (S): 708 @ $3.13 · Sale (S): 1,799 @ $3.13 · Sale (S): 1,576 @ $3.13 · Sale (S): 2,463 @ $3.13 | EDGAR |
| 2025-06-04 | 4 | Lehman David Aaron — GENERAL COUNSEL | Sale (S): 535 @ $3.14 · Sale (S): 943 @ $3.13 · Sale (S): 3,597 @ $3.13 · Sale (S): 2,099 @ $3.13 · Sale (S): 3,283 @ $3.13 | EDGAR |
| 2025-06-04 | 4 | Florin Daniel P — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-06-04 | 4 | Mead Dana G Jr. — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-06-04 | 4 | Ferrari Richard — Director | Grant/award (A): 37,153 @ $0 | EDGAR |
| 2025-03-21 | 4 | French Glendon E. III — Director | Sale (S): 20,000 @ $7.85 | EDGAR |
| 2025-03-05 | 4 | Joshi Mehul — Chief Financial Officer & PAO | Sale (S): 14,384 @ $7.12 · Grant/award (A): 108,000 @ $0 | EDGAR |
| 2025-03-05 | 4 | Williamson Steven S. — PRESIDENT AND CEO, Director | Sale (S): 27,689 @ $7.14 · Grant/award (A): 181,696 @ $0 · Grant/award (A): 128,395 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Lehman David Aaron — GENERAL COUNSEL | Sale (S): 669 @ $7.14 · Sale (S): 1,177 @ $7.14 · Sale (S): 4,490 @ $7.14 · Sale (S): 2,397 @ $7.14 · Sale (S): 13,622 @ $7.97 · Grant/award (A): 108,000 @ $0 | EDGAR |
| 2025-03-05 | 4 | Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER | Sale (S): 520 @ $7.12 · Sale (S): 915 @ $7.12 · Sale (S): 2,327 @ $7.14 · Sale (S): 2,017 @ $7.12 · Grant/award (A): 108,000 @ $0 | EDGAR |
| 2025-02-24 | 4 | French Glendon E. III — Director | Sale (S): 43,036 @ $8.14 · Sale (S): 12,417 @ $8.76 | EDGAR |
Recent 8-K events — Pulmonx Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-03-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-10-27 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-05-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LUNG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →